Top Markets
#1 PulseChain PulseChain +44.89%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +17.88%
#3 RedStone RedStone +15.77%
#4 MarsCoin MarsCoin +13.40%
#5 SkyAI SkyAI +10.21%
#6 Lighter Lighter +9.20%
#7 Meteora Meteora +9.19%
#8 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +8.24%
#9 Monad Monad +7.59%
#10 OPENLOOT OPENLOOT +7.54%
Coin of the day
PulseChain PulseChain
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Oncocross Co., Ltd. Oncocross Co., Ltd.

Oncocross Co., Ltd.

382150
Rang in aandelen #27869
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover... Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Aandeelprijs
$2.50
Marktkapitalisatie
$30.49M
Verandering (1 dag)
7.11%
Verandering (1 jaar)
-59.56%
Land
KR
Handel Oncocross Co., Ltd. (382150)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Oncocross Co., Ltd. (382150)
Het dividendrendement (TTM) van Oncocross Co., Ltd. (aandelsymbool: 382150) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Oncocross Co., Ltd. (382150) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten
Bedrijf Dividendrendement Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.12%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH